BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33258481)

  • 1. Validation of a prostate cancer polygenic risk score.
    Black MH; Li S; LaDuca H; Lo MT; Chen J; Hoiness R; Gutierrez S; Tippin-Davis B; Lu HM; Gielzak M; Wiley K; Shi Z; Wei J; Zheng SL; Helfand BT; Isaacs W; Xu J
    Prostate; 2020 Nov; 80(15):1314-1321. PubMed ID: 33258481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes.
    Kote-Jarai Z; Mikropoulos C; Leongamornlert DA; Dadaev T; Tymrakiewicz M; Saunders EJ; Jones M; Jugurnauth-Little S; Govindasami K; Guy M; Hamdy FC; Donovan JL; Neal DE; Lane JA; Dearnaley D; Wilkinson RA; Sawyer EJ; Morgan A; Antoniou AC; Eeles RA;
    Ann Oncol; 2015 Apr; 26(4):756-761. PubMed ID: 25595936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRState: Incorporating genetic ancestry in prostate cancer risk scores for men of African ancestry.
    Pagadala MS; Linscott JA; Talwar JV; Seibert TM; Rose B; Lynch J; Panizzon M; Hauger R; Hansen MH; Sammon JD; Hayn MH; Kader K; Carter H; Ryan ST
    BMC Cancer; 2022 Dec; 22(1):1289. PubMed ID: 36494783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer.
    Castro E; Mikropoulos C; Bancroft EK; Dadaev T; Goh C; Taylor N; Saunders E; Borley N; Keating D; Page EC; Saya S; Hazell S; Livni N; deSouza N; Neal D; Hamdy FC; Kumar P; Antoniou AC; Kote-Jarai Z; ; Eeles RA
    Oncologist; 2016 Jun; 21(6):716-22. PubMed ID: 27151655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of SNPs associated with prostate cancer in men of Ashkenazic descent from the set of GWAS identified SNPs: impact of cancer family history and cumulative SNP risk prediction.
    Agalliu I; Wang Z; Wang T; Dunn A; Parikh H; Myers T; Burk RD; Amundadottir L
    PLoS One; 2013; 8(4):e60083. PubMed ID: 23573233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a simple prostate cancer risk prediction model based on age, family history, and polygenic risk.
    Dite GS; Spaeth E; Murphy NM; Allman R
    Prostate; 2023 Jul; 83(10):962-969. PubMed ID: 37062910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genome-wide association study of prostate cancer in Latinos.
    Du Z; Hopp H; Ingles SA; Huff C; Sheng X; Weaver B; Stern M; Hoffmann TJ; John EM; Van Den Eeden SK; Strom S; Leach RJ; Thompson IM; Witte JS; Conti DV; Haiman CA
    Int J Cancer; 2020 Apr; 146(7):1819-1826. PubMed ID: 31226226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common genetic variants associated with disease from genome-wide association studies are mutually exclusive in prostate cancer and rheumatoid arthritis.
    Orozco G; Goh CL; Al Olama AA; Benlloch-Garcia S; Govindasami K; Guy M; Muir KR; Giles GG; Severi G; Neal DE; Hamdy FC; Donovan JL; Kote-Jarai Z; Easton DF; Eyre S; Eeles RA
    BJU Int; 2013 Jun; 111(7):1148-55. PubMed ID: 22985493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.
    Schumacher FR; Al Olama AA; Berndt SI; Benlloch S; Ahmed M; Saunders EJ; Dadaev T; Leongamornlert D; Anokian E; Cieza-Borrella C; Goh C; Brook MN; Sheng X; Fachal L; Dennis J; Tyrer J; Muir K; Lophatananon A; Stevens VL; Gapstur SM; Carter BD; Tangen CM; Goodman PJ; Thompson IM; Batra J; Chambers S; Moya L; Clements J; Horvath L; Tilley W; Risbridger GP; Gronberg H; Aly M; Nordström T; Pharoah P; Pashayan N; Schleutker J; Tammela TLJ; Sipeky C; Auvinen A; Albanes D; Weinstein S; Wolk A; Håkansson N; West CML; Dunning AM; Burnet N; Mucci LA; Giovannucci E; Andriole GL; Cussenot O; Cancel-Tassin G; Koutros S; Beane Freeman LE; Sorensen KD; Orntoft TF; Borre M; Maehle L; Grindedal EM; Neal DE; Donovan JL; Hamdy FC; Martin RM; Travis RC; Key TJ; Hamilton RJ; Fleshner NE; Finelli A; Ingles SA; Stern MC; Rosenstein BS; Kerns SL; Ostrer H; Lu YJ; Zhang HW; Feng N; Mao X; Guo X; Wang G; Sun Z; Giles GG; Southey MC; MacInnis RJ; FitzGerald LM; Kibel AS; Drake BF; Vega A; Gómez-Caamaño A; Szulkin R; Eklund M; Kogevinas M; Llorca J; Castaño-Vinyals G; Penney KL; Stampfer M; Park JY; Sellers TA; Lin HY; Stanford JL; Cybulski C; Wokolorczyk D; Lubinski J; Ostrander EA; Geybels MS; Nordestgaard BG; Nielsen SF; Weischer M; Bisbjerg R; Røder MA; Iversen P; Brenner H; Cuk K; Holleczek B; Maier C; Luedeke M; Schnoeller T; Kim J; Logothetis CJ; John EM; Teixeira MR; Paulo P; Cardoso M; Neuhausen SL; Steele L; Ding YC; De Ruyck K; De Meerleer G; Ost P; Razack A; Lim J; Teo SH; Lin DW; Newcomb LF; Lessel D; Gamulin M; Kulis T; Kaneva R; Usmani N; Singhal S; Slavov C; Mitev V; Parliament M; Claessens F; Joniau S; Van den Broeck T; Larkin S; Townsend PA; Aukim-Hastie C; Gago-Dominguez M; Castelao JE; Martinez ME; Roobol MJ; Jenster G; van Schaik RHN; Menegaux F; Truong T; Koudou YA; Xu J; Khaw KT; Cannon-Albright L; Pandha H; Michael A; Thibodeau SN; McDonnell SK; Schaid DJ; Lindstrom S; Turman C; Ma J; Hunter DJ; Riboli E; Siddiq A; Canzian F; Kolonel LN; Le Marchand L; Hoover RN; Machiela MJ; Cui Z; Kraft P; Amos CI; Conti DV; Easton DF; Wiklund F; Chanock SJ; Henderson BE; Kote-Jarai Z; Haiman CA; Eeles RA; ; ; ; ; ; ; ; ;
    Nat Genet; 2018 Jul; 50(7):928-936. PubMed ID: 29892016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of clinically significant prostate cancer using polygenic risk models in Asians.
    Song SH; Kim E; Woo E; Kwon E; Yoon S; Kim JK; Lee H; Oh JJ; Lee S; Hong SK; Byun SS
    Investig Clin Urol; 2022 Jan; 63(1):42-52. PubMed ID: 34983122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease.
    Sipeky C; Tammela TLJ; Auvinen A; Schleutker J
    Prostate Cancer Prostatic Dis; 2021 Dec; 24(4):1158-1166. PubMed ID: 34012061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translating genetic risk factors for prostate cancer to the clinic: 2013 and beyond.
    Mikropoulos C; Goh C; Leongamornlert D; Kote-Jarai Z; Eeles R
    Future Oncol; 2014; 10(9):1679-94. PubMed ID: 25145435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine mapping of 11q13.5 identifies regions associated with prostate cancer and prostate cancer death.
    Nurminen R; Lehtonen R; Auvinen A; Tammela TL; Wahlfors T; Schleutker J
    Eur J Cancer; 2013 Oct; 49(15):3335-43. PubMed ID: 23830236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide association study identifies new prostate cancer susceptibility loci.
    Schumacher FR; Berndt SI; Siddiq A; Jacobs KB; Wang Z; Lindstrom S; Stevens VL; Chen C; Mondul AM; Travis RC; Stram DO; Eeles RA; Easton DF; Giles G; Hopper JL; Neal DE; Hamdy FC; Donovan JL; Muir K; Al Olama AA; Kote-Jarai Z; Guy M; Severi G; Grönberg H; Isaacs WB; Karlsson R; Wiklund F; Xu J; Allen NE; Andriole GL; Barricarte A; Boeing H; Bueno-de-Mesquita HB; Crawford ED; Diver WR; Gonzalez CA; Gaziano JM; Giovannucci EL; Johansson M; Le Marchand L; Ma J; Sieri S; Stattin P; Stampfer MJ; Tjonneland A; Vineis P; Virtamo J; Vogel U; Weinstein SJ; Yeager M; Thun MJ; Kolonel LN; Henderson BE; Albanes D; Hayes RB; Feigelson HS; Riboli E; Hunter DJ; Chanock SJ; Haiman CA; Kraft P
    Hum Mol Genet; 2011 Oct; 20(19):3867-75. PubMed ID: 21743057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis.
    Siltari A; Lönnerbro R; Pang K; Shiranov K; Asiimwe A; Evans-Axelsson S; Franks B; Kiran A; Murtola TJ; Schalken J; Steinbeisser C; Bjartell A; Auvinen A;
    Clin Genitourin Cancer; 2023 Apr; 21(2):316.e1-316.e11. PubMed ID: 36243664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a multi-ancestry polygenic risk score and age-specific risks of prostate cancer: A meta-analysis within diverse populations.
    Chen F; Darst BF; Madduri RK; Rodriguez AA; Sheng X; Rentsch CT; Andrews C; Tang W; Kibel AS; Plym A; Cho K; Jalloh M; Gueye SM; Niang L; Ogunbiyi OJ; Popoola O; Adebiyi AO; Aisuodionoe-Shadrach OI; Ajibola HO; Jamda MA; Oluwole OP; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Mensah JE; Adjei AA; Diop H; Lachance J; Rebbeck TR; Ambs S; Gaziano JM; Justice AC; Conti DV; Haiman CA
    Elife; 2022 Jul; 11():. PubMed ID: 35801699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array.
    Saunders EJ; Dadaev T; Leongamornlert DA; Al Olama AA; Benlloch S; Giles GG; Wiklund F; Gronberg H; Haiman CA; Schleutker J; Nordestgaard BG; Travis RC; Neal D; Pasayan N; Khaw KT; Stanford JL; Blot WJ; Thibodeau SN; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park JY; Kaneva R; Batra J; Teixeira MR; Pandha H; Govindasami K; Muir K; ; ; ; Easton DF; Eeles RA; Kote-Jarai Z
    Br J Cancer; 2016 Apr; 114(8):945-52. PubMed ID: 26964030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores.
    Lecarpentier J; Silvestri V; Kuchenbaecker KB; Barrowdale D; Dennis J; McGuffog L; Soucy P; Leslie G; Rizzolo P; Navazio AS; Valentini V; Zelli V; Lee A; Amin Al Olama A; Tyrer JP; Southey M; John EM; Conner TA; Goldgar DE; Buys SS; Janavicius R; Steele L; Ding YC; Neuhausen SL; Hansen TVO; Osorio A; Weitzel JN; Toss A; Medici V; Cortesi L; Zanna I; Palli D; Radice P; Manoukian S; Peissel B; Azzollini J; Viel A; Cini G; Damante G; Tommasi S; Peterlongo P; Fostira F; Hamann U; Evans DG; Henderson A; Brewer C; Eccles D; Cook J; Ong KR; Walker L; Side LE; Porteous ME; Davidson R; Hodgson S; Frost D; Adlard J; Izatt L; Eeles R; Ellis S; Tischkowitz M; ; Godwin AK; Meindl A; Gehrig A; Dworniczak B; Sutter C; Engel C; Niederacher D; Steinemann D; Hahnen E; Hauke J; Rhiem K; Kast K; Arnold N; Ditsch N; Wang-Gohrke S; Wappenschmidt B; Wand D; Lasset C; Stoppa-Lyonnet D; Belotti M; Damiola F; Barjhoux L; Mazoyer S; ; Van Heetvelde M; Poppe B; De Leeneer K; Claes KBM; de la Hoya M; Garcia-Barberan V; Caldes T; Perez Segura P; Kiiski JI; Aittomäki K; Khan S; Nevanlinna H; van Asperen CJ; ; Vaszko T; Kasler M; Olah E; Balmaña J; Gutiérrez-Enríquez S; Diez O; Teulé A; Izquierdo A; Darder E; Brunet J; Del Valle J; Feliubadalo L; Pujana MA; Lazaro C; Arason A; Agnarsson BA; Johannsson OT; Barkardottir RB; Alducci E; Tognazzo S; Montagna M; Teixeira MR; Pinto P; Spurdle AB; Holland H; ; Lee JW; Lee MH; Lee J; Kim SW; Kang E; Kim Z; Sharma P; Rebbeck TR; Vijai J; Robson M; Lincoln A; Musinsky J; Gaddam P; Tan YY; Berger A; Singer CF; Loud JT; Greene MH; Mulligan AM; Glendon G; Andrulis IL; Toland AE; Senter L; Bojesen A; Nielsen HR; Skytte AB; Sunde L; Jensen UB; Pedersen IS; Krogh L; Kruse TA; Caligo MA; Yoon SY; Teo SH; von Wachenfeldt A; Huo D; Nielsen SM; Olopade OI; Nathanson KL; Domchek SM; Lorenchick C; Jankowitz RC; Campbell I; James P; Mitchell G; Orr N; Park SK; Thomassen M; Offit K; Couch FJ; Simard J; Easton DF; Chenevix-Trench G; Schmutzler RK; Antoniou AC; Ottini L
    J Clin Oncol; 2017 Jul; 35(20):2240-2250. PubMed ID: 28448241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.
    Amin Al Olama A; Kote-Jarai Z; Schumacher FR; Wiklund F; Berndt SI; Benlloch S; Giles GG; Severi G; Neal DE; Hamdy FC; Donovan JL; Hunter DJ; Henderson BE; Thun MJ; Gaziano M; Giovannucci EL; Siddiq A; Travis RC; Cox DG; Canzian F; Riboli E; Key TJ; Andriole G; Albanes D; Hayes RB; Schleutker J; Auvinen A; Tammela TL; Weischer M; Stanford JL; Ostrander EA; Cybulski C; Lubinski J; Thibodeau SN; Schaid DJ; Sorensen KD; Batra J; Clements JA; Chambers S; Aitken J; Gardiner RA; Maier C; Vogel W; Dörk T; Brenner H; Habuchi T; Ingles S; John EM; Dickinson JL; Cannon-Albright L; Teixeira MR; Kaneva R; Zhang HW; Lu YJ; Park JY; Cooney KA; Muir KR; Leongamornlert DA; Saunders E; Tymrakiewicz M; Mahmud N; Guy M; Govindasami K; O'Brien LT; Wilkinson RA; Hall AL; Sawyer EJ; Dadaev T; Morrison J; Dearnaley DP; Horwich A; Huddart RA; Khoo VS; Parker CC; Van As N; Woodhouse CJ; Thompson A; Dudderidge T; Ogden C; Cooper CS; Lophatonanon A; Southey MC; Hopper JL; English D; Virtamo J; Le Marchand L; Campa D; Kaaks R; Lindstrom S; Diver WR; Gapstur S; Yeager M; Cox A; Stern MC; Corral R; Aly M; Isaacs W; Adolfsson J; Xu J; Zheng SL; Wahlfors T; Taari K; Kujala P; Klarskov P; Nordestgaard BG; Røder MA; Frikke-Schmidt R; Bojesen SE; FitzGerald LM; Kolb S; Kwon EM; Karyadi DM; Orntoft TF; Borre M; Rinckleb A; Luedeke M; Herkommer K; Meyer A; Serth J; Marthick JR; Patterson B; Wokolorczyk D; Spurdle A; Lose F; McDonnell SK; Joshi AD; Shahabi A; Pinto P; Santos J; Ray A; Sellers TA; Lin HY; Stephenson RA; Teerlink C; Muller H; Rothenbacher D; Tsuchiya N; Narita S; Cao GW; Slavov C; Mitev V; ; ; ; ; Chanock S; Gronberg H; Haiman CA; Kraft P; Easton DF; Eeles RA
    Hum Mol Genet; 2013 Jan; 22(2):408-15. PubMed ID: 23065704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A polygenic risk score for breast cancer risk in a Taiwanese population.
    Hsieh YC; Tu SH; Su CT; Cho EC; Wu CH; Hsieh MC; Lin SY; Liu YR; Hung CS; Chiou HY
    Breast Cancer Res Treat; 2017 May; 163(1):131-138. PubMed ID: 28205043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.